Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

William Sheridan(The Royal Melbourne Hospital), R. M. Fox(The Royal Melbourne Hospital), C. Glenn Begley(Clinical Emergency Hospital Bucharest), Dermot Maher(Clinical Emergency Hospital Bucharest), Katherine McGrath(Clinical Emergency Hospital Bucharest), C. Glenn Begley(Clinical Emergency Hospital Bucharest), Christopher A. Juttner(Royal Adelaide Hospital), Luen Bik To(Royal Adelaide Hospital), Jeff Szer, G. Mostyn(Ludwig Cancer Research)

The Lancet

March 1, 1992

10.1016/0140-6736(92)90795-5

Cited by 880

Abstract

Related Papers

The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors

D Metcalf|Blood|1986|890

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern et al.|The Lancet|1989|751

Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients

Ulrich Dührsen, Jean‐Luc Villeval, James Boyd et al.|Blood|1988|593

GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

MarkA. Socinski, Anthony Elias, Lowell E. Schnipper et al.|The Lancet|1988|571

Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Ian McNiece, Keith Langley, K M Zsebo|PubMed|1991|438